Background Shorter dual antiplatelet therapy (DAPT) regimens may offer a more favourable risk-benefit profile compared with longer treatment. The aim of this study was to determine the optimal ...
Mounting evidence indicates that nuclear receptors play a critical regulatory role in platelet pathophysiology and thrombotic disorders. Although NR4A (the nuclear receptor subfamily 4 group A) plays ...
Chemotherapy-induced thrombocytopenia is a low platelet count caused by chemo drugs damaging bone marrow cells that produce platelets. This happens because chemo targets all quickly replicating cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results